Merdury Biopharmaceutical Corporation (TPEX:6932)
Taiwan · Delayed Price · Currency is TWD 7.98
-0.01 (-0.13%)
May 8, 2026, 1:52 PM CST
Merdury Biopharmaceutical Market Cap
Merdury Biopharmaceutical has a market cap or net worth of 3.37 billion as of May 8, 2026. Its market cap has decreased by -38.35% in one year.
Market Cap
3.37B
Enterprise Value
3.25B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
7.98
Market Cap Chart
Since December 23, 2022, Merdury Biopharmaceutical's market cap has decreased from 5.10B to 3.37B, a decrease of -34.01%. That is a compound annual growth rate of -11.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 3.37B | -3.03% |
| Dec 31, 2025 | 3.47B | -36.83% |
| Dec 31, 2024 | 5.50B | -29.32% |
| Dec 29, 2023 | 7.78B | 94.15% |
| Dec 30, 2022 | 4.01B | -21.50% |
| Dec 23, 2022 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient Pharma | 5.81B |
| LIWANLI Innovation | 5.68B |
| SCI Pharmtech | 5.58B |
| Easywell Biomedicals | 4.49B |
| Orient EuroPharma | 4.04B |
| Allied Biotech | 3.07B |
| Maywufa Company | 2.88B |
| Johnson Chemical Pharmaceutical Works | 2.41B |